Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients

Abstract

A linear kinetic model of glucagon intervention has been developed and validated. It is expected to provide guidance for glucagon delivery and the construction of preclinical simulation testing platforms.